Search Results 1861-1870 of 18429 for polycystic ovary syndrome
D., discusses new findings on tolvaptan as autosomal dominant polycystic kidney disease treatment. Kelly Reller. November 4, 2017. Mayo Clinic researchers find ...
Vicente Torres, M.D., Ph.D., discusses new findings on tolvaptan as autosomal dominant polycystic kidney disease treatment. Kelly Reller. November 4, 2017.
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
Staff skilled in dozens of specialties work together to ensure quality care and successful recovery. Departments that treat this condition. Cardiovascular ...
Learn how medications and bone marrow transplants are used to control complications caused by these syndromes that affect the bone marrow.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.